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In a novel application of two-photon scanning ¯uores-
cence microscopy, three-dimensional spatial distribu-
tions of the hydrophilic and hydrophobic ¯uorescent
probes, sulforhodamine B and rhodamine B hexyl
ester, in excised full-thickness human cadaver skin
were visualized and quanti®ed. Both sulforhodamine
B and rhodamine B hexyl ester were observed to lie
primarily in the lipid multilamellae region surround-
ing the corneocytes within the stratum corneum.
From the two-photon scanning ¯uorescence micro-
scopy scans, the changes in the concentration gradi-
ent and the vehicle to skin partition coef®cient of
each probe induced by the oleic acid enhancer action
were calculated relative to the control sample (not
exposed to oleic acid), and subsequently applied to
theoretically derived mathematical expressions of
transdermal transport to quantitatively characterize
the oleic acid-induced relative changes in the skin
diffusion coef®cient and the skin barrier diffusion
length of the permeant. For the hydrophobic probe
rhodamine B hexyl ester, the permeability enhance-
ment was primarily driven by an increase in the
vehicle to skin partition coef®cient, leading to an
increase in the steepness of the concentration gradi-
ent across the skin. The primary oleic acid-induced
changes in the transport properties of the hydro-
philic probe sulforhodamine B included increases
in the vehicle to skin partition coef®cient and the
skin diffusion coef®cient. These ®ndings utilizing
the two-photon scanning ¯uorescence microscopy
methodology and data analysis described here
demonstrate that, in addition to providing three-
dimensional images that clearly delineate probe dis-
tributions in the direction of increasing skin depth,
the subsequent quanti®cation of these images pro-
vides additional important insight into the mechanis-
tic changes in transdermal transport underlying the
visualized changes in probe distributions across the
skin. Key words: chemical enhancement mechanism/excised
human skin/¯uorescent probe distribution/oleic acid/two-
photon scanning ¯uorescence microscopy. J Invest Dermatol
117:16±25, 2001
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s a noninvasive alternative to more traditional
methods of drug delivery, including oral and
subcutaneous administration, transdermal drug de-
livery offers the advantages of patient compliance
and elimination of ®rst-pass drug metabolism
(Finnin and Morgan, 1999). The inherent barrier properties of
the stratum corneum (SC), the outermost layer of the skin,
limits transdermal delivery to molecules that are hydrophobic
and have low molecular weight (Guy, 1996). Whereas the
ordered con®guration of the lipid multilamellae that comprise
the continuous phase of the SC creates a barrier to drug
penetration (Scheuplein and Blank, 1971; Potts and Francoeur,
1991), the af®nity of small hydrophobic molecules for the
``oily'' environment of the bilayer hydrocarbon tail region
enables the transdermal delivery of drugs such as scopolamine,
clonidine, nitroglycerine, estradiol, fetanyl, and nicotine
(Cullander and Guy, 1992; Schaefer and Redelmeier, 1996).
The pharmaceutical relevance of many molecules, such as
peptides, proteins, and other large hydrophilic molecules, which
are excluded from the category of small hydrophobic molecules,
has stimulated the investigation of permeability enhancement
methods, such as, the application of chemical compounds to the
skin to reversibly alter its resistance to drug transport (Golden et al,
1987; Francoeur et al, 1990; Naik et al, 1995; Yoneto et al, 1995;
Johnson et al, 1996b; Peck et al, 1998). A description and
understanding of the processes involved in chemically enhanced
transdermal drug transport would enable the rational design of
drug-chemical enhancer formulations, an otherwise time consum-
ing and costly process.
Experimental techniques utilized in mechanistic studies of
chemically induced transdermal drug permeability enhancement
have included Fourier transform infrared spectroscopy, differen-
tial scanning calorimetry, and nuclear magnetic resonance
spectroscopy (Schaefer and Redelmeier, 1996). For oleic acid,
a well-known chemical enhancer, these techniques have been
helpful in identifying the mode of chemical enhancer action as
a ¯uidization of the lipid multilamellae which form the
continuous phase of the SC (Francoeur et al, 1990; Schaefer
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and Redelmeier, 1996). The correlation found between
increased transdermal drug ¯ux and increased lipid ¯uidity
strongly suggests that oleic acid alters the packing structure of
the SC lipids to increase lipid ¯uidity and reduce skin resistance
to drug transport (Golden et al, 1987). Furthermore, the
mechanism of oleic acid chemical enhancer action has been
associated with the formation of phase-separated oleic acid
domains in the SC multilamellar lipids (Ongpipattanakul et al,
1991). Whereas the above-mentioned studies (Golden et al,
1987; Francoeur et al, 1990; Schaefer and Redelmeier, 1996)
have clearly elucidated the role of oleic acid in altering SC lipid
ordering, the changes in the microscale transport properties of
the permeant, including the vehicle to skin partition coef®cient,
the skin diffusion coef®cient, and the skin barrier diffusion
length, that underlie the experimentally measured increases in
the transdermal permeability of the permeant, remain to be
clari®ed.
Laser scanning confocal ¯uorescence microscopy has been
utilized to visualize hydrophobic and hydrophilic ¯uorescent
probe spatial distributions across the skin (Turner and Guy,
1997; Kuijk-Meuwissen et al, 1998); however, three-dimen-
sional imaging using this technique is limited by increased light
scattering within the medium. In laser scanning confocal
¯uorescence microscopy, the ¯uorescent probe penetration is,
therefore, often imaged by sectioning skin samples perpendicular
to the skin surface such that the ®eld of view captures the
¯uorescent probe distribution from the SC to the dermis all in
one plane. Because skin sample sections often undergo exposure
to chemicals and mechanical forces in the curing, setting, and
sectioning stages of the sample preparation procedure, the
presence of artifacts in the ®nal sample remains a potential risk.
As a noninvasive method for directly visualizing the skin
structural features, TPM has been successfully used to image
in vivo human skin (Masters et al, 1998). More recently, TPM has
been utilized to visualize in vitro permeant spatial distributions
across human cadaver skin.1±3 In TPM, tight focusing in a laser
scanning microscope, combined with a femtosecond pulsed laser,
enables a dye molecule to simultaneously absorb two long-
wavelength photons to reach its excited state (Denk et al, 1990).
The quadratic dependence of the excitation probability results in
greater three-dimensional depth discrimination. The long-wave-
length photon source used in TPM allows deeper light penetration
into media with a high degree of scattering (Denk et al, 1995;
Diaspro, 1999; Soeller and Cannell, 1999), thus making it well
suited for imaging the skin (Masters et al, 1998).
Other attributes of TPM include its use of a large area signal
detector that maximizes the photon collection ef®ciency, and
the localization of the excitation volume to the focal region,
which results in minimized photodamage and photobleaching
(Masters et al, 1997; Periasamy et al, 1999).
Despite the application of TPM to visualize probe distribu-
tions in the skin (Grewal et al 2000), to date, TPM scans of
¯uorescent probe distributions in the skin have not been
rigorously analyzed to characterize quantitatively the changes in
the transdermal transport properties resulting from chemical
enhancer action. The structural complexity of the SC (described
below) poses signi®cant challenges to the quantitative analysis of
average probe transport properties in the skin. This analysis
relies on an accurate assessment of the ¯uorescent probe
concentration distributions throughout the skin depth. To
demonstrate the quantitative analysis methodology described
below in detail, the SC was treated as a membrane in which
the corneocytes and lipid multilamellae are collectively con-
sidered in the quanti®cation of the ¯uorescent probe distribu-
tions in the SC. This approach, in which the corneocytes were
not excluded from the analysis of transdermal permeant
transport, has been commonly employed by other researchers
(Mak et al, 1990; Naik et al, 1995; Pirot et al, 1997). Hence,
the ensuing description of the TPM methodology utilized in
the transdermal transport studies and the quanti®cation of the
changes detected in the microscale transport properties relative
to the control case, introduce, for the ®rst time, the novel
application of TPM to this in vitro model skin system to
elucidate the mechanism of chemical enhancer action.
In the studies reported here, three-dimensional images of
¯uorescent probe spatial distributions across full-thickness human
cadaver skin were constructed utilizing TPM data. Oleic acid-
induced changes in the probe concentration gradient, as well as
in the microtransport properties of the probe, including the skin
diffusion coef®cient, the skin barrier diffusion length, and the
vehicle to skin partition coef®cient, all of which in¯uence the
experimentally measured permeability of the probe across the
skin, were quanti®ed relative to the control case (without oleic
acid) based on a theoretical analysis of these three- dimensional
images to shed light on the mechanisms of chemically enhanced
transdermal transport.
The SCÐthe outermost 10±20 mm layer of the skinÐis the
primary barrier to transdermal drug transport (Bommannan et al,
1990), and consists of corneocytes embedded in a continuous
phase of lipid multilamellae (LB), as depicted in the schematic
illustration of the brick and mortar model of the SC including
the viable epidermis (VE) shown in Fig 1. The two-photon
microscopy images discussed below will highlight permeant
diffusion across the SC and a portion of the underlying VE.
The steady-state ¯ux, J, of a permeant across the SC
membrane in the absence of convective solvent ¯ow is
Figure 1. Schematic illustration of the brick and mortar model of
the SC, including the VE. The corneocytes (C) and keratinocytes (K)
are represented by the brick-like structures in the continuous phase of
the lipid bilayer lamellae (LB) that comprise the intercellular space. In
the SCÐthe ®rst 10±20 mm of the skinÐcorneocytes have estimated
dimensions of 40 mm in diameter and 0.8 mm in thickness, whereas the
intercellular space thickness is estimated to be 75 nm. The keratinocytes
(10 mm in diameter) in the VE undergo compression (7±0.8 mm) as they
differentiate and migrate to the SC to form the corneocytes.
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commonly described using the one dimensional Fick's First Law
of diffusion, namely,
J  ÿD dC
dz
1
where D is the effective permeant diffusion coef®cient in the
membrane, and dC/dz is the concentration gradient in the z-
direction, or the direction of increasing SC depth (Peck et al, 1996;
Pugh et al, 1998). From Eqn 1, changes in the permeant ¯ux are
driven by changes in two microtransport properties, D and dC/dz.
Additional transport properties that contribute to the experimen-
tally measured permeant skin permeability include the permeant
vehicle to skin partition coef®cient, K, and the skin barrier
diffusion length, l. As discussed later, the skin barrier diffusion
length, l, represents the thickness of the skin region over which the
greatest barrier to permeant transdermal transport is exhibited. In
discussions of percutaneous absorption, in which a constant donor
solution concentration and a zero concentration receiver solution
were assumed, the mathematical models derived for transdermal
transport yield expressions for diffusion in one dimension
(Scheuplein, 1967; Pirot et al, 1997). With z/R < < 1, where z
and R are the skin depth and the skin diffusion area radius,
respectively, and with the donor solution-imposed concentration
gradient in the z-direction, the mathematical expression for
multidimensional transport can be simpli®ed to one dimension
(Deen, 1998).
Currently, experimental methods are not available to determine
directly the permeant diffusion coef®cient in the skin in vitro, and
SC models have relied on measurements of diffusion coef®cients in
liposomes of various lipid compositions (Johnson et al, 1996a). In
this study, we will focus on the oleic acid enhancer induced
changes in the relevant transport properties discussed above, relative
to the experimental control (without the enhancer), for each probe
examined. The quanti®cation of the relative change for each
transport property under investigation is reported as an enhance-
ment factor, E, which is the ratio of the value of the transport
property with and without the chemical enhancer. From TPM
data, the relative change in the vehicle to skin partition coef®cient
for each probe can be directly determined. Consequently, the
relative change in the probe diffusion coef®cient due to oleic acid
enhancer action can be calculated using the following expression
relating the probe ¯ux, J, to its permeability, P (Schaefer and
Redelmeier, 1996):
P = J/DC (2)
where DC is the difference in the probe concentration between the
donor and the receiver compartments of the side-by-side diffusion
cell used to measure P. For a given value of DC, the permeability
enhancement, EP, which is the ratio of the permeant permeability
in the presence of the chemical enhancer and that of the control
(without the chemical enhancer), can be obtained by using Eqn 2
in Eqn 1, and then taking the ratio of the resulting expression for
the chemical enhancer (E) and the control (C) samples. Speci®cally,
EP  DE
DC
dC
dz
 
E
dC
dz
 
C
0BBB@
1CCCA 3
where the ®rst derivative, or the slope, of the linear permeant
concentration pro®le (discussed later) established in the SC at
steady-state conditions is a constant quantity. Note that EP = PE/
PC can be calculated from the ratio of the measured transdermal
permeabilities of each permeant at the two conditions (E and C)
examined. Recall that, in general, the permeant permeability can be
obtained as follows:
P  1
AC
dN
dt
 
r
4
where (dN/dt)r is the change in the amount of permeant over time
in the receiver compartment, and A is the area of the skin exposed
to the donor solution. Moreover, for the steady-state transport of a
permeant through biologic membranes, the permeant partition
coef®cient between the donor solution and the skin, K, and the
skin barrier diffusion length, l, also play signi®cant parts in
determining the magnitude of the permeability coef®cient, P.
Speci®cally (Schaefer and Redelmeier, 1996),
P  KD
l
5
Using Eqn 5, one can express the permeability enhancement, EP, in
the following alternate useful form:
EP  PE
PC
 EKED
El
6
where the partition-coef®cient enhancement, EK, the diffusion-
coef®cient enhancement, ED, and the skin barrier diffusion length
enhancement, El, are given, respectively, by
ED  DE
DC
7
EK  KE
KC
8
and
El  lE
lC
9
Substituting Eqn 3 in Eqn 6, the skin barrier diffusion length
enhancement, El, can be expressed in the following useful form:
El  EK
Eg
10
where
Eg 
dC
dz
 
E
dC
dz
 
C
11
is the concentration-gradient enhancement. Equation 10 allows the
calculation of the skin barrier diffusion length enhancement, El,
utilizing quantities that are readily available through TPM experi-
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ments. Indeed, as shown below, both the concentration-gradient
enhancement, Eg, and the partition-coef®cient enhancement, EK,
can be extracted solely from the data obtained from the TPM
three-dimensional scans of the ¯uorescent probe spatial distribu-
tions to determine the skin barrier diffusion length enhancement,
El, which describes the relative change in the thickness of the
permeant diffusion barrier in the z-direction resulting from the
chemical enhancer action.
MATERIALS AND METHODS
Preparation of skin sample for imaging Full-thickness human
cadaver skin from the abdominal area (National Disease Research
Interchange, Philadelphia, PA), acquired 10±20 h post mortem, was
stored at ± 80°C and utilized within 3±6 wk. Upon use, the skin was
thawed at room temperature (25°C), and the fat from the dermal side
was removed. Skin samples of 2.25 cm2 were mounted in side-by-side
diffusion cells (9 mm diameter, PermeGear, Riegelsville, PA), and then
immersed in phosphate-buffered saline (PBS; 0.01 M phosphate buffer,
0.0027 M KCl and 0.137 NaCl, pH = 7.4; Sigma, St Louis, MO) for the
measurement of skin conductivities.
Skin conductivity measurements Skin conductivities for all the skin
samples examined were measured as an indicator of the skin barrier
integrity (Kontturi et al, 1993; Peck et al, 1994; Kalia and Guy, 1995).
Ag±AgCl electrodes (E242, In Vivo Metric, Healdsburg, California) were
connected to an AC signal generator (HP 33120A 15 MHz Function
Arbitrary Waveform Generator, Hewlett Packard, Palo Alto, California)
in series with a digital multimeter (Radio Shack, Fort Worth, TX). One
electrode was placed in each compartment of the diffusion cell, ®lled
with PBS, and a voltage drop of 100 mV was applied across the skin. To
a 10 Hz current reading, the conductivity criterion of > 10 kW cm2 was
applied (Rossel et al, 1988), with skin samples not meeting this criterion
replaced by intact skin.
Fluorescent probe properties The two ¯uorescent probes (Molecular
Probes, Eugene, OR), rhodamine B hexyl ester perchlorate (RBHE) and
sulforhodamine B (SRB), served as the hydrophobic and hydrophilic
model drugs, respectively, and were selected based on their similarity in
molecular structure, disparity in octanol±water partition coef®cient, and
¯uorescence emission range. Figure 2(a,b) show the chemical structures
of the two ¯uorescent probes, with their molecular weights (MW),
¯uorescence absorption (ab) and emission (em) spectral peaks (ab/em),
and log KO/PBS (where KO/PBS is the experimentally determined
octanol±PBS partition coef®cient) listed in Table I. Whereas similar in
structure, slight differences in the functional groups of RBHE and SRB
result in octanol±PBS partition coef®cients that vary by three orders of
magnitude. The absence of the sulfate groups (SO3
±) and the addition of
the hexyl ester moiety (C6H13COO) in RBHE, compared with SRB,
impart a greater tendency for hydrophobic interactions. The log KO/PBS
values measured for RBHE and SRB are 2.49 and ±0.45, respectively,
clearly re¯ecting their roles as the hydrophobic and hydrophilic model
drugs.
In addition to their physicochemical properties, these two probes were
selected to minimize the effects of the skin auto¯uorescence, character-
ized by absorption and emission peaks of 488 nm and 515 nm, respect-
ively (Masters et al, 1997). Speci®cally, under the 780 nm laser
excitation, the ¯uorescence signals of the probes, their spectral absorp-
tion/emission peaks at 556 nm/578 nm (RBHE) and 565 nm/586 nm
(SRB), have minimal overlap with that corresponding to the skin
auto¯uorescence. Photon counts at each depth of the skin samples, kept
in contact with the vehicles and in the absence of any ¯uorescent probes,
maintained an average value of 1 and lower, with SD of up to 3 photon
counts. These values clearly indicate that the signal detected in the
presence of the ¯uorescent probe does indeed originate from the
¯uorescent probe alone, as the samples exposed to the ¯uorescent probes
yielded average photon counts that are greater by two orders of
magnitude.
Donor solution preparation Donor vehicle solutions of RBHE and
SRB consisting of ethanol (100%, Pharmco Products, Brook®eld, CT)
and PBS (Sigma, St Louis, MO), at a 1 : 1 ratio, by volume, were
prepared at concentrations of 0.5 mg per ml and 0.7 mg per ml,
respectively. In preparing the solutions containing the model chemical
enhancer, an additional 5% by volume of oleic acid (99%, Sigma) was
added to the PBS/ethanol probe solutions. Skin samples were left in
contact with well-stirred donor solutions for 48 h, until the steady-state
diffusion pro®le was established.
Measurement of ®nal skin conductivities The ®nal skin
conductivities of the samples were again measured as described above to
determine the changes in the skin barrier function due to chemical
enhancer action, as conductivity measurements have frequently served as
a useful indicator of the skin barrier function, and conductivity increases
have similarly been found to correlate well with permeant permeability
increases (Sims et al, 1991). Compared with the skin samples for which
no changes in conductivity were measured after 48 h of contact with
only PBS (the control caseÐno chemical enhancer), the skin samples
treated with the oleic acid chemical enhancer indeed lowered the skin
barrier function. The measured changes in skin conductivities for the
samples kept in contact with the oleic acid solution are comparable with
the 100±200-fold skin conductivity increases cited in the literature for
skin treated with chemical enhancers (Inamori et al, 1994; Li et al, 1998).
Skin preparation for TPM imaging Each skin sample was then
removed and rinsed with PBS/ethanol (1 : 1, by volume) and blotted
with a Kimwipe (Kimberly Clark, Roswell, GA) to ensure the removal
of any excess ¯uorescent probes present on the surface of the skin. The
circular area of the skin exposed to the probes was cut out with a
surgical carbon steel razor blade (VWR Scienti®c, Media, PA), and then
sealed in an imaging chamber (2.5 mm Coverwell, Grace Bio-
Laboratories, Bend, OR) with a no. 1, 22 mm square coverslip (VWR
Scienti®c, Media, PA) contacting the SC side. A drop of PBS was added
to the chamber to prevent the sample drying out.
Permeability measurements Control (no chemical enhancer) and
chemical enhancer solutions of RBHE and SRB, prepared as described
above, were radiolabeled with the equivalent tritiated probe (American
Radiolabeled Chemicals, St Louis, MO) at 1 mCi per ml. Following the
procedure described in the literature, the permeability measurements
were performed (Johnson et al, 1996a) in triplicate using heat-stripped
skin (Peck et al, 1994; (Li et al, 1998) with each of the four probe-
vehicles, RBHE-control, RBHE-enhancer, SRB-control, and SRB-
enhancer, serving as the donor solution for each set of experiments. The
skin conductivities were measured before and after the experiments, as
described above for each sample examined. The presence of radiolabeled
permeants was detected with a liquid scintillation analyzer (2200CA Tri-
Figure 2. Chemical structures of the two ¯uorescent model drugs
examined. (a) RBHE is the hydrophobic model drug, and (b) SRB is
the hydrophilic analog. The two molecules are similar in molecular
weight, 627 Da and 559 Da, respectively, but are distinguished by
functional groups that impart drastic differences in octanol±PBS partition
coef®cients, KO/PBS. RBHE lacks the two SO3
± groups present in SRB,
but the hexyl ester group contributes to the higher KO/PBS values
measured for RBHE compared with SRB (see Table I).
Table I. Fluorescent probe properties of the hydrophobic
(RBHE) and hydrophilic (SRB) model probes examineda
Probe RBHE SRB
MW (Da) 627 559
ab/em (nm) 556/578 565/586
log KO/PBS
b 2.49 6 0.18 ±0.45 6 0.0045
aThe chemical structures of RBHE and SRB are illustrated in Fig 2(a,b),
respectively. MW, molecular weight of each probe; ab/em, the probe spectral
absorption (ab) and emission peaks (em); log KO/PBS, measured values of the log
of the probe PBS±octanol partition coef®cients (described in the Materials and
Methods section).
bValues are reported as mean 6 SD. Experiments were performed in triplicate.
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Carb, Packard Instrument Company, Downers Grove, IL), and the
steady-state permeant permeabilities were calculated utilizing Eqn 4.
Determination of probe octanol±PBS partition coef®cients To
obtain a calibration curve of ¯uorescence intensity vs concentration,
solutions of varying concentrations were prepared by diluting the stock
for each ¯uorescent probe. The ¯uorescence intensity at each known
probe concentration was then measured with a ¯uorescence system
(Photon Technology International, Monmouth Junction, NJ).
Two milliliters of each probe solution in PBS (» 0.05 mg per ml for
RBHE and » 0.07 mg per ml for SRB) were vortexed for 30 s with
2 ml of octanol (Fisher Scienti®c, Pittsburgh, PA) in a glass vial.
Experiments were performed in triplicate. The vortexed mixtures were
then allowed to equilibriate for 24 h. The aqueous phases were measured
with the ¯uorescence system and the corresponding concentration was
determined utilizing a calibration curve of probe concentration vs probe
¯uorescence intensity. Following the measurement of the initial and ®nal
probe concentrations in the aqueous phase, the quantity of probe in the
octanol phase was determined by the difference between the initial and
®nal concentrations of the aqueous phase. The probe octanol±PBS
partition coef®cient was calculated by taking the ratio of the ®nal probe
concentration in the octanol phase and that in the PBS phase. The
octanol±PBS partition coef®cients obtained here (log KO/PBS = 2.49 6
0.18 and ±0.45 6 0.0045 for RBHE and SRB, respectively; see
Table I) illustrate that for the concentrations used, SRB and RBHE act
as the model hydrophilic and lipophilic molecules, respectively.
Two-photon microscope The TPM instrument used in this study is
shown in Fig 3, with a general description of the instrumentation
located elsewhere (So et al, 1998). In these studies, a femtosecond
titanium-sapphire laser (Tsunami, Spectra-Physics, Mountain View, CA)
pumped by a 5 W diode-pumped, solid-state continuous wave (CW)
laser (Millennia, Spectra-Physics, Mountain View, CA) provided the
two-photon excitation at 780 nm. The microscope system consisted of a
modi®ed inverted microscope (Axiovert 100TV, Zeiss, Thornwood,
NY), a 40 3 objective lens (Zeiss F Fluar, NA 0.13), and an objective
micropositioner (model p-721 PIFOC, Physik Instrumente, Germany).
X±Y scans are achieved using a scanner unit (Cambridge Technology,
Watertown, MA), and photon pulses from the photomultiplier are
discriminated against dark noise with an ampli®er-discriminator unit
(model F-100T, Advanced Research Instrument Corporation, Boulder,
CO).
Data collection Per skin sample, four to six TPM scans of the
¯uorescence probe spatial distributions at different skin coordinates, or
skin sites, were collected for each of the four treated skin samples
(RBHE-control, RBHE-enhancer, SRB-control, and SRB-enhancer).
The laser power (» 2 mW) was adjusted such that the ¯uorescence
intensity emitted by the sample remained below the detection saturation
threshold. The signal detection saturation threshold, below which a
linear correlation exists between the ¯uorescence counts detected and the
quantity of ¯uorescent probe present in the sample, was determined
utilizing standard probe solutions of known concentrations.
Data analysis Three-dimensional images of the TPM data were
examined with Spyglass Slicer (Spyglass, Inc., Lexington, MA) data
visualization software on a personal computer (Dimension XPS D300,
Dell, Round Rock, TX). A corresponding average probe ¯uorescence
spatial distribution pro®le was calculated with an in-lab subroutine (Eric
Ho, Massachusetts Institute of Technology, Cambridge, MA) for each
three-dimensional scan. At each depth (z-coordinate) scanned, the
subroutine averages the ¯uorescence counts associated with the pixels in
the 256 by 256 pixel image representing the imaged ®eld. For each site
analyzed by the subroutine, a plot of the average ¯uorescence count vs
the corresponding skin depth generates the site-speci®c average
¯uorescent probe spatial distribution pro®le (SSDP), which is the
quantitative representation of the three-dimensional visualization
generated with Spyglass Slicer.
Generation of ¯uorescent probe intensity pro®les Per skin sample,
the surface of each of the four to six sites examined, corresponding to
z = 0 mm, was de®ned by the scanning depth yielding the highest
average ¯uorescence count. The de®nition of these surfaces normalized
the different SSDP and enabled the subsequent calculation of the sample
average intensity pro®le (SAIP) for each probe-vehicle combination
based on the four to six sites surveyed. In calculating each SAIP, the
¯uorescence counts associated with each individual SSDP corresponding
to a given z-coordinate were averaged. This average was then plotted vs
the corresponding z-coordinate to yield the SAIP, I(z). The calculated
SD from the SAIP represent the site to site variations in probe
penetration within a particular skin sample.
Fluorescent probe intensity gradient calculation The intensity
gradient (or the slope) corresponding to each SAIP was calculated by
performing a linear regression for the data points comprising the ®rst 11
axial scans, or 8 mm, of the skin, a region encompassing the drastic
decrease in probe intensity for the control cases (in the absence of
chemical enhancer) to which chemical enhancer-induced changes in
probe transport are compared. The error in the intensity gradient
corresponding to each SAIP is expressed as the range in which a 95%
con®dence level exists (see Table II).
Because of the direct correlation between the probe ¯uorescence
intensity and the probe concentration established with the standard probe
solutions described above, the shape of the SAIP provides a good
representation of the probe concentration pro®le in the skin sample.
Hence, the calculation of the concentration-gradient enhancement, Eg,
for each probe results from substituting the values of dI/dz, listed in
Table II, for those of the corresponding probe concentration gradients,
dC/dz (see Eqn 11).
Figure 3. Schematic illustration of the TPM. Based on a point-
scanning approach, the instrument utilizes a tight focal spot in three-
dimensional imaging. Incident beams of light emitted from the diode
laser pumped titanium-sapphire are de¯ected by the X±Y scanner to
different angular positions, and then directed to the microscope system
(area enclosed by the dotted lines). From the ®eld-aperture plane, the
laser is re¯ected from the dichroic mirror to the microscope objective.
The skin sample is placed below the microscope objective, with the
piezo-z stage controlling the scanner in the z-direction. Signal photons
from the sample are processed with the photomultiplier tube/
discriminator, and data analysis is performed with the computer.
Table II. Linear regression results for the sample average
intensity pro®les of the skin samples examineda
Probe
dI/dz
(counts per mm) R2
RBHE (C) ±7.66 6 0.21 0.99
RBHE (E) ±41.16 6 1.67 0.99
SRB (C) ±8.37 6 0.38 0.98
SRB (E) ±10.42 6 0.58 0.97
aThe reported intensity gradients, dI/dz, are the slopes of the SAIP correspond-
ing to the ®rst 8 mm of each skin sample examined, and were obtained from linear
regressions (see Materials and Methods). The control and enhancer vehicles are
denoted by (C) and (E), respectively. The error reported for dI/dz re¯ects the
range of intensity gradient values that fall within a 95% con®dence level based on
the precision of the linear ®t.
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Moreover, the intensity gradient of each SSDP was calculated in the
same manner, and then averaged to assess the relationship between the
sample average intensity gradient and the corresponding site-speci®c
intensity gradient.
Quanti®cation of changes in the probe vehicle to skin partition
coef®cient For each probe, the concentration difference between the
donor and the receiver diffusion cell compartments, DC (see Eqn 2), was
approximated by the probe donor concentration Cd because Cd/Cr @ 1,
where Cr is the probe concentration in the receiver compartment.
Hence, under these in®nite sink conditions, Cd remains a fairly constant
quantity in the control and the chemical enhancer permeability studies
for both SRB and RBHE.
With a constant Cd value for the control and the enhancer solutions
for each probe, and given that K = Cs|0/Cd (Schaefer and Redelmeier,
1996), where K is the probe vehicle to skin partition coef®cient and
Cs|0 is de®ned as the probe concentration in the skin at the surface (at
z = 0 mm) (Pirot et al, 1997; Deen, 1998), the probe vehicle to skin
partition-coef®cient enhancement, EK, was approximated for each probe
by taking the ratio of the average ¯uorescence intensity at the skin
surface (corresponding to z = 0 mm) for the enhancer and the control
samples. Speci®cally,
EK  IEz jz0
ICz jz0 12
where IE(z) and IC(z) represent the average intensities of the probe for
the enhancer and the control cases, respectively. For these studies, the
skin volume associated with the concentration of the probe detected at
the skin surface corresponds to the volume de®ned by the area of the
®eld scanned and the two-photon laser beam point size in the axial or z-
direction. Because the relative change in the probe vehicle to skin
partition coef®cient is the quantity of interest here, for the same skin
surface volume, only the average probe surface intensity is considered.
RESULTS
Three-dimensional visualization of ¯uorescent probe spatial
distributions in the skin To illustrate the qualitative details
that one can obtain using the TPM z-scans, representative three-
dimensional images of the probe spatial concentration (or intensity)
distributions for one site of the four sites examined per skin sample
are shown in Fig 4(a±d). Each three-dimensional construct
represents a ®eld of 112 3 112 mm and a depth of 32 mm from
the surface of the skin. The color scales used for these images are
also shown in Fig 4, where regions in red (corresponding to 300)
re¯ect regions of high probe concentration and regions in blue
(corresponding to 0) re¯ect regions of low probe concentration.
The C in each part of the ®gure points to structures resembling
corneocytes.
Hydrophobic probe RBHE Figure 4(a,b) illustrates the spatial
distributions of the hydrophobic probe RBHE across the
thickness of the skin sample (32 mm) without (the control) and
with the chemical enhancer oleic acid, respectively. Illustrating that
the SC acts as the primary barrier to transdermal transport, the
majority of the drop in intensity for RBHE occurs over the
Figure 4. Three-dimensional probe distribu-
tions in the upper 32 mm of the skin sample.
(a,b) Depict the hydrophobic probe (RBHE) spatial
distributions resulting from the control and the
chemical enhancer vehicles, respectively. (c,d)
Depict the hydrophilic probe (SRB) spatial
distributions resulting from the control and the
chemical enhancer vehicles, respectively. To
highlight the structural features, quadrants of 8 and
16 mm in depth are removed from the respective
probe distribution images, as shown by the length
scales drawn on the control samples for each probe.
The color scale indicates an increase in probe
concentration as the colors progress from 0 to 300.
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uppermost layers of the skin, approximately over 10 mm, limiting
the ¯uorescence signal detection beyond that depth (see Fig 4a,b).
Hydrophilic probe SRB Figure 4(c,d) illustrates the spatial
distributions of the hydrophilic probe SRB across the skin sample
(32 mm). For the hydrophilic probe, SRB, in the control condition
(see Fig 4c), the majority of the drop in probe intensity also occurs
in the uppermost layers of the skin. In the presence of the oleic acid
enhancer, however, the gradual decline of SRB concentration
across the SC and into the VE (see Fig 4d) suggests that the
chemical enhancer has reduced the SC barrier properties such that
the contribution of the VE to the overall skin barrier becomes more
noticeable.
Similarities between RBHE and SRB For both RBHE and SRB,
the presence of oleic acid is qualitatively observed to increase the
quantity of each probe on the surface of the skin (cf. Fig 4a and
Fig 4b for RBHE, and Fig 4c and Fig 4d for SRB), which is
indicative of increased partitioning of the probe into the skin.
Moreover, the quantities of RBHE and SRB detected in the
control samples are signi®cantly lower as they lie in the blue region
of the color scale (see Fig 4a,c). Increases in both the partition
coef®cient and the concentration gradient of the probe due to the
presence of oleic acid should contribute to an increase in the overall
transdermal transport of the probe, as described by Eqns 1 and 5.
Based on these three-dimensional images, regions of high probe
concentration surround the corneocytes, suggesting that the
primary transport pathway across the skin is through the lipid
multilamellar regions between the corneocytes for both the
hydrophobic and the hydrophilic model drugs examined. Because
the resolution of these two-photon microscope images is limited by
the laser scanning spot size of » 1 mm, molecular scale details are
not visually accessible. Nevertheless, as discussed above and shown
below, changes in the transport microenvironment can be inferred
from a quanti®cation of these images.
Differences between RBHE and SRB Although both the
hydrophobic and the hydrophilic model drugs examined appear
to traverse the skin primarily via the intercellular route, the
differences observed in the nature of the probe spatial distributions
throughout the skin samples suggest that oleic acid enhancer action
operates through different mechanisms for these two model drugs.
These qualitative differences include the pronounced decrease
observed in the average intensity for the hydrophobic probe over
the ®rst 8 mm of the skin sample, represented by the changes in the
color scale from green to blue and from red to blue (see Fig 4a,b),
for the control and the enhancer samples, respectively. A similar
decrease in probe ¯uorescence signal, from green to blue (see
Fig 4c), was detected for the hydrophilic probe over the ®rst
16 mm in the control skin sample, but its spatial distribution in the
presence of oleic acid enhancer changed, showing the perfusion of
hydrophilic probe throughout the 32 mm of the skin sample (see
Fig 4d), highlighted by the regions in red. Insight into these
differences in transport mechanisms can be gained from a more
quantitative analysis of the two-photon data, which is presented
next.
Quanti®cation of the ¯uorescent probe spatial distributions
in the skin Figures 5 and 6 show the measured average
photon counts vs skin depth, representing the respective average
concentration pro®les of the hydrophobic (RBHE) and the
hydrophilic (SRB) model drugs as described in the Materials and
Methods section. (The estimated instrumentation error in the z
direction is 5%.) The average intensity pro®le at the skin surface
(z = 0 mm) is proportional to the magnitude of the probe skin±
vehicle partition coef®cient, and the slope of the curve corresponds
to the probe concentration gradient.
Quanti®cation of the relative change in the probe vehicle±skin partition
coef®cient, EK The higher probe concentrations detected at the
surfaces of the three-dimensional representations of the oleic acid
treated samples (see Fig 4b,d) agree with their corresponding probe
intensity pro®les in which 4-fold increases in the average photon
counts are measured at z = 0 mm (cf. h and j in Figs 5 and 6). A
calculation of the probe partition-coef®cient enhancement, EK,
utilizing the IE and IC values obtained from the SAIP at z = 0 mm,
yields values of 4.33 6 3.45 and 4.56 6 2.05 for the hydrophobic
and the hydrophilic probes, respectively. The partitioning of both
the hydrophobic and the hydrophilic probes from the control
solution (1 : 1 PBS/ethanol) into the skin is enhanced to a similar
degree in the presence of the oleic acid enhancer. For both probes,
the large error in EK arises from the site to site variation of the
probe average ¯uorescence pro®les, as seen in Figs 5 and 6, in
which the error bars re¯ect the variation in the SSDP detected at
each skin depth (z-coordinate). The deduced EK values further
substantiate the increased partitioning of both RBHE and SRB
from the vehicle to the skin in the presence of the oleic acid
chemical enhancer shown in Fig 4b and d, respectively.
Quanti®cation of the relative change in the probe intensity gradient, Eg In
addition to the partition-coef®cient enhancement, the intensity
gradients were calculated (see Materials and Methods section) for the
SAIP in Figs 5 and 6, and the results are reported in Table II with
respect to the slope and R2 corresponding to the linear regression.
The error corresponding to the slope calculations represents the
statistical range in which a 95% con®dence level exists. As expected
from the SAIP, the intensity gradients for RBHE and SRB in the
control vehicles are similar, with values of ±7.66 6 0.21 counts per
mm and ±8.37 6 0.38 counts per mm, respectively; however, the
presence of the oleic acid enhancer signi®cantly increases the
steepness of the intensity gradient of RBHE (dI/dz = ± 41.16 6
1.67 counts per mm), while having little effect on the SRB intensity
gradient (dI/dz = ± 10.42 6 0.58 counts per mm). Based on the
slope values determined, the concentration-gradient enhancements
are Eg = 5.37 6 0.26 for RBHE and Eg = 1.24 6 0.09 for SRB,
indicating that the RBHE ¯ux enhancement results from an
increase in the concentration gradient, one of the factors driving
permeant ¯ux across the skin (see Eqn 1), as well as by increased
probe partitioning into the skin.
Quanti®cation of site-speci®c probe intensity gradients The average
intensity gradients calculated from the SAIP were compared with
the intensity gradients obtained from each speci®c site examined by
performing a linear regression of the SSDP. The four to six SSDP
(not shown) that generate each SAIP revealed variations in probe
intensity at each depth that were twice as large as those observed at
the corresponding depth of the SAIP. These statistics suggest that
the error bars associated with each SAIP may be reduced with
increased sampling of different sites on the skin sample. Based on
the statistics of a normal distribution, the error associated with each
Figure 5. Sample average intensity pro®les of RBHE. Key: sample
average intensity counts calculated at each depth for the control (j) and
the enhancer (h) vehicles. The average photon counts is plotted vs the
corresponding skin depth. The error bars indicate 1 SD from the sample
average intensity of the ®ve and six different sites sampled for each
condition, respectively.
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SAIP should decrease by the square root of the number of SSDP
utilized in the analysis.
Table III reports the individual site-speci®c probe intensity
gradient values followed by the average of those values for each of
the SSDP belonging to each of the four cases examined (RBHE-
control, RBHE-enhancer, SRB-control, and SRB-enhancer). The
control and enhancer cases corresponding to RBHE for the SAIP
intensity gradient (± 7.66 6 0.21 and ±41.16 6 1.67) and the
average of the SSDP intensity gradients (± 7.66 6 3.72 and
±41.17 6 26.65) revealed nearly identical means. Whereas the
averages of the SSDP intensity gradients (± 9.65 6 2.58, control;
±15.43 6 4.47, enhancer) calculated for SRB were, in general,
more negative in value than the corresponding SAIP intensity
gradients (± 8.37 6 0.38, control; ±10.42 6 0.58, enhancer), the
differences between the two intensity gradient calculations are
ultimately captured within their error bars. The analysis of the
SSDP intensity gradients presented above suggests that the
application of the SAIP in the methodology introduced here serves
as an average representation of the different SSDP sampled.
A discussion of the changes in the skin barrier diffusion length
and the skin diffusion coef®cient of the permeant deduced from the
permeability enhancement, EP, concentration-gradient enhance-
ment, Eg, and partition-coef®cient enhancement, EK, for RBHE
and SRB is presented below.
Quanti®cation of oleic acid-induced changes in transdermal
transport properties The enhancements of the concentration
gradient, Eg, vehicle to skin partition coef®cient, EK, permeability
coef®cient, EP, skin barrier diffusion length, El, and diffusion
coef®cient, ED, are shown in Fig 7. The error bars represent 1 SD
from the average value, except for Eg, for which the error bars
indicate a 95% con®dence level in the results (described in Materials
and Methods). Factors contributing to the enhanced permeability
values for the hydrophilic probe (EP = 9.59 6 2.92) and the
hydrophobic probe (EP = 7.35 6 1.00) are immediately revealed
by the Eg and EK values. The Eg values corresponding to the probe
concentration gradients increased by 5.37 6 0.26 (gray bar in
Fig 7) and 1.24 6 0.09 (striped bar in Fig 7), for the hydrophobic
(RBHE) and the hydrophilic (SRB) probes, respectively. Despite
the negligible change in the concentration gradient obtained for
SRB in the presence of oleic acid, the value for EK (4.56 6 2.05,
striped bar in Fig 7) suggests that the main driving force for ¯ux
enhancement in this case is due to the SRB increased af®nity for
the SC.
As shown in Fig 6, the average intensity pro®le for SRB
maintains a similar shape in both the presence and the absence of
oleic acid, but is translated in the direction of increasing intensity by
a factor of 4 in the presence of oleic acid. For RBHE, both Eg and
EK clearly indicate increases in the average concentration gradient
and skin partitioning in the presence of oleic acid with values of
5.37 6 0.26 and 4.33 6 3.45 (gray bars in Fig 7), respectively.
These results presented for both the hydrophilic and the
hydrophobic probes are consistent with the two-layer transdermal
diffusion model proposed by Yamashita et al (1995), who used
Figure 6. Sample average intensity pro®les of SRB. Key: sample
average intensity counts calculated at each depth for the control (j) and
the enhancer (h) vehicles. The average photon counts is plotted vs the
corresponding skin depth. The error bars indicate 1 SD from the sample
average intensity of the four and ®ve different sites sampled for each
condition, respectively.
Table III. SSDP linear regression results for each site examineda
RBHE SRB
Site no. dI/dz (C) R2 dI/dz (E) R2 dI/dz (C) R2 dI/dz (E) R2
1 ±3.18 0.99 ±20.30 0.97 ±6.60 0.98 ±22.03 1.00
2 ±5.93 0.99 ±20.30 0.98 ±10.48 0.94 ±16.63 1.00
3 ±13.00 0.96 ±52.80 0.96 ±12.71 0.98 ±15.53 0.98
4 ±9.42 0.98 ±88.70 0.98 ±8.82 1.00 ±10.11 1.00
5 ±6.78 0.99 ±40.60 0.95 ± ± ±12.84 1.00
6 ± ± ±24.29 0.95 ± ± ± ±
AVGb ±7.66 6 3.72 ±41.17 6 26.65 ±9.65 6 2.58 ±15.43 6 4.47
aThe linear regression for each SSDP was performed for the ®rst 11 axial scans at each site to obtain the intensity gradient, dI/dz. The value of dI/dz for each site is
reported for the control (C) and enhancer (E) cases. The R2 value following each reported dI/dz value describes the accuracy of the linear ®t.
bFor each group of SSDP, the average value, AVG, of the intensity gradients calculated for the respective number of sites imaged per skin sample is reported as the
mean 6 SD.
Figure 7. Relative changes in transport parameters. Key: RBHE
(gray bars), SRB (striped bars). With the exception of Eg, the error bars
indicate 1 SD from the mean. The error bars corresponding to Eg for
both probes represent the upper and the lower limit of a 95% con®dence
level. The enhancement factors calculated for RBHE are:
Eg = 5.37 6 0.26, EK = 4.33 6 3.45, EP = 7.35 6 1.00, El = 0.81 6
0.64, and ED = 1.37 6 0.20. The enhancement values calculated for
SRB are: Eg = 1.24 6 0.09, EK = 4.56 6 2.05, EP = 9.59 6 2.92,
El = 3.66 6 1.67, and ED = 7.70 6 2.41.
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mannitol (polar) and 6-mercaptopurine (nonpolar) as the model
drugs in a system that accounts for the existence of both a polar and
a nonpolar permeant transport route through the SC. For both
routes, their results showed that the oleic acid action increased their
model parameter associated with permeant partitioning from the
vehicle to the skin (Yamashita et al, 1995).
Quanti®cation of oleic acid-induced changes in the SC microtransport
environment as re¯ected in ED and El The oleic acid-induced
changes in the hydrophilic probe microtransport environment that
promote increased transdermal diffusion are discussed next. From
the relative changes in the intensity gradient, Eg, and the skin
partition coef®cient, EK, one can subsequently estimate the changes
that arise in the permeant skin barrier diffusion length, re¯ected in
El, and in the permeant skin diffusion coef®cient, re¯ected in ED. El
is calculated using Eqn 10, in which the permeant skin barrier
diffusion length enhancement is simply the ratio of EK and Eg, the
two enhancement factors readily obtained using the SAIP shown in
Figs 5 and 6. By applying Eqn 6, in which ED can now be
obtained as a function of EP, EK, and El upon rearranging the
equation, the quantitative changes in the permeant skin diffusion
coef®cient can be obtained.
For the hydrophilic probe, SRB, in the presence of oleic acid, an
increase in the skin barrier diffusion length was calculated, as well as
clearly visualized in Fig 6 (h). Based on Eqn 5, an increase in the
skin barrier diffusion length would contribute to a decrease in the
permeability, but the concomitant increase in probe partition
coef®cient, EK = 4.56 6 2.05, and diffusion coef®cient, ED =
7.70 6 2.41, offsets the increase in skin barrier diffusion length,
El = 3.66 6 1.67
In contrast to the changes estimated for the microtransport
properties of the hydrophilic probe, the skin barrier diffusion length
and diffusion coef®cient of the hydrophobic probe, RBHE, show
minor deviations from the control condition in the presence of
oleic acid, as re¯ected in the values of El = 0.81 6 0.64 and
ED = 1.37 6 0.20, respectively.
The deduced values for the both the skin barrier diffusion length
enhancement and the diffusion-coef®cient enhancement are
discussed below, ®rst for the hydrophilic probe, SRB, and
subsequently for the hydrophobic probe, RBHE.
DISCUSSION
Implications of changes detected in the hydrophilic probe
transport properties The observed increase in the skin barrier
diffusion length (El = 3.66 6 1.67) for the hydrophilic probe in
the presence of oleic acid suggests the creation of a microtransport
environment in the SC, which is more amenable to hydrophilic
drug transport, such that the predominant skin barrier now includes
both the SC and the viable epidermis. The precise signi®cance of
the 4-fold increase in the skin barrier diffusion length, with respect
to the physical dimensions and structural components of the
different skin layers, requires further investigation. As revealed by
the increase in the diffusion coef®cient (ED = 7.70 6 2.41), the
permeant microenvironment has noticeably changed to allow for
the increased mobility of SRB. Therefore, the diffusion of the
hydrophilic permeant exhibits a greater sensitivity to changes in the
lipid environment because of its inherent incompatibility with the
SC lipid environment under passive conditions. The increases
measured for the vehicle to skin partition coef®cient, the skin
barrier diffusion length, and the diffusion coef®cient re¯ect
microenvironmental changes in the SC. The relationship
between the microenvironmental changes reported here and the
microscale descriptions of transport pathway changes noted in the
literature, such as, increases in the hydrophilic permeant pathway
pore sizes (Yamashita et al, 1995) as well as oleic acid phase
separation and domain formation in the SC lipid region
(Ongpipattanakul et al, 1991), requires further investigation.
Implications of changes detected in the hydrophobic probe
transport properties Compared with the signi®cant increase
detected in the skin barrier diffusion length for the hydrophilic
probe, the minor change in this value for the hydrophobic probe
(El = 0.81 6 0.64) indicates that, even in the presence of oleic acid
enhancer action, the SC comprises the primary barrier to
transdermal transport, as the deeper layers of the skin do not
contribute to the transport barrier delineated by the drop in the
probe concentration across the ®rst 8 mm of the skin. The minor
effect of oleic acid on the microtransport environment of the
hydrophobic probe, as re¯ected in the ED value of 1.37 6 0.20,
can be attributed to the natural intrinsic compatibility of the
hydrophobic probe with the SC lipid environment.
The increase in SC lipid ¯uidity associated with oleic acid
enhancer action, in this case, is primarily manifested by the
increased partitioning of the hydrophobic molecule into the skin,
re¯ected in EK = 4.33 6 3.45, followed by the increased concen-
tration gradient driving transdermal diffusion, re¯ected in
Eg = 5.37 6 0.26. The error bars shown on the SAIP curves
re¯ect the heterogeneity of the SC and result from the spread in the
individual pixel intensities for each SSDP. We believe that these
large variations (twice as large as those observed for the SAIP) in the
SSDP are mainly dominated by the skin location morphologic
variation on the micron scale. In the presence of oleic acid chemical
enhancer action, the variance for both RBHE (Fig 5, h) and SRB
(Fig 6, h), increases, as re¯ected in the increased size of the error
bars relative to the control cases (Figs 5 and 6, j). In light of this
observation, additional variance may also result from the nonuni-
form action of the oleic acid. A heterogeneous distribution of oleic
acid throughout the SC may result from the formation of separate
domains of oleic acid pools within the SC lipids (Ongpipattanakul
et al, 1991).
Based on the data presented, the variance due to SC morphology
may be reduced by sampling over larger areas at each site in the skin
sample; however, as the sampling area increases, the intrinsic
heterogeneity of the skin properties and the nonuniform action of
the oleic acid chemical enhancer may become more evident.
Further studies over larger skin areas may enable us to address better
the site to site variations observed in the skin model.
Moreover, the application of an alternative approach, where
regions containing no probe (corneocyte regions) are excluded
from the average intensity calculation, may provide information
pertaining to the probe diffusion and distribution on the submicron
scale. By evaluating only the probe-rich regions, this approach
eliminates the morphology-dependent contribution to the spread in
SSDP variations. Whereas the methodology applied in our studies
has examined probe transport through a medium consisting of two
different components (corneocytes and lipid multilamellae), the
alternative analysis method focuses more speci®cally on transport
through the continuous phase of the SC (the lipid regions). Hence,
this approach decomposes the SC into its more fundamental
components, and evaluates one aspect of the overall mechanism of
transdermal transport. Future studies involving the rigorous com-
parison of results arising from the two data analysis schemes, as well
as an increased sampling of skin sites, will provide additional insight
into the mechanism of chemical enhancer action.
CONCLUSIONS
The advantages of TPM in providing three-dimensional images
detailing the chemical enhancer-induced changes in ¯uorescent
probe distributions in the upper 32 mm of skin samples, with
respect to important structural features such as the corneocytes and
the lipid multilamellar region, have been demonstrated here. More
importantly, we have presented here, for the ®rst time, a
methodology that quantitatively characterizes the signi®cance of
the visualized differences in these three-dimensional images with
respect to the commonly investigated permeant transport para-
meters. The agreement between the apparent changes in probe
concentration gradient, probe partitioning, probe diffusion coef®-
cient, and probe skin barrier diffusion length, estimated using this
method, and the phenomenologic explanations of permeability
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enhancement detailed in the literature illustrates the potential of
two-photon microscopy in elucidating the mechanisms of
transdermal transport processes at the mechanistic level. The results
presented above for this in vitro model system, in addition to the
noninvasive nature of TPM, reinforces the potential applicability of
utilizing this method in future studies to understand the changes
underlying the experimentally measured permeabilities for in vivo
systems.
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